Nelson Jen An Chao, MD

Professor of Medicine
Donald D. and Elizabeth G. Cooke Cancer Research Professor
Professor in Immunology
Professor in Pathology
Member of the Duke Cancer Institute
Chief, Division of Cell Therapy in the Department of Medicine
Affiliate of the Regeneration Next Initiative
Campus mail 2400 Pratt St Suite 5000, DUMC Box 3961, Durham, NC 27710
Phone (919) 668-1000
Email address nelson.chao@duke.edu

My research interests are in two broad areas, clinical hematopoietic stem cell and cord blood transplantation and in the laboratory studies related to graft vs. host disease and immune reconstitution. On the clinical side we are currently conducting approximately 50 different clinical protocols ranging from preparatory regimens, supportive care studies and disease specific protocols. Most of these clinical studies are centered around studies of the sources of stem cells and the methods to improve the long term outcome. There are exploratory protocols for novel therapies such as dendritic cell therapy for several malignancies, antiangiogenesis therapy, graft engineering to prevent graft-versus-host disease and antigen specific T cells or non specific NK cells to prevent relapse. Moreover a strong focus of the program is to develop cord-blood transplantation for adult patients with hematologic malignancies. The laboratory studies center on understanding the immunological events that occur with graft-vs-host disease and methods to prevent this disease. The current efforts focus on understanding murine reconstitution following transplantation, use of a peptide polymer to block MHC class II recognition of minor histocompatibility antigens, use of T cell engineering to prevent graft-versus-host disease at the same time preserving a graft-versus-malignancy effect.

For more information see http://ed-media.mc.duke.edu/BMT.nsf

In Their Words

Education and Training

  • Fellow in Oncology, Medicine, Stanford University, 1985 - 1987
  • Medical Resident, Medicine, Stanford University, 1981 - 1984
  • M.D., Yale University, 1981

Publications

Schlegel, P. G., R. Aharoni, Y. Chen, J. Chen, D. Teitelbaum, R. Arnon, M. Sela, and N. J. Chao. “Erratum: A synthetic random basic copolymer with promiscuous binding to class II major histocompatibility complex molecules (Proceedings of the National Academy of Science of the United States of America (May 14, 1996) 93:10 (5061-5066)).” Proceedings of the National Academy of Sciences of the United States of America 93, no. 16 (January 1, 1996).

Scholars@Duke

Kastrissios, H., N. J. Chao, and T. F. Blaschke. “Pharmacokinetics of high-dose oral CCNU in bone marrow transplant patients..” Cancer Chemother Pharmacol 38, no. 5 (1996): 425–30. https://doi.org/10.1007/s002800050506.

PMID
8765435
Full Text

Chao, N. J., and P. G. Schlegel. “Prevention and treatment of graft-versus-host disease..” Ann N Y Acad Sci 770 (December 29, 1995): 130–40.

PMID
8597355
Scholars@Duke

Chao, N. J. “Mobilization of peripheral blood progenitor cells by hematopoietic growth factors..” Can J Oncol 5 Suppl 1 (December 1995): 43–46.

PMID
8853524
Scholars@Duke

Zaia, J. A., G. M. Schmidt, N. J. Chao, N. W. Rizk, A. P. Nademanee, J. C. Niland, D. A. Horak, J. Lee, G. Gallez-Hawkins, and C. R. Kusnierz-Glaz. “Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: long-term follow-up..” Biol Blood Marrow Transplant 1, no. 2 (December 1995): 88–93.

PMID
9118297
Scholars@Duke

O’Donnell, M. R., G. D. Long, P. M. Parker, J. Niland, A. Nademanee, M. Amylon, N. Chao, R. S. Negrin, G. M. Schmidt, and M. L. Slovak. “Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia..” J Clin Oncol 13, no. 12 (December 1995): 2973–79. https://doi.org/10.1200/JCO.1995.13.12.2973.

PMID
8523063
Full Text

Parker, P. M., N. Chao, A. Nademanee, M. R. O’Donnell, G. M. Schmidt, D. S. Snyder, A. S. Stein, et al. “Thalidomide as salvage therapy for chronic graft-versus-host disease..” Blood 86, no. 9 (November 1, 1995): 3604–9.

PMID
7579470
Scholars@Duke

Schlegel, P. G., M. Vaysburd, Y. Chen, E. C. Butcher, and N. J. Chao. “Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers..” J Immunol 155, no. 8 (October 15, 1995): 3856–65.

PMID
7561092
Scholars@Duke

Long, G. D., R. S. Negrin, C. F. Hoyle, C. R. Kusnierz-Glaz, J. R. Schriber, K. G. Blume, and N. J. Chao. “Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies..” Cancer 76, no. 5 (September 1, 1995): 860–68.

PMID
8625190
Scholars@Duke

Fernandez, L. P., P. G. Schlegel, J. Baker, Y. Chen, and N. J. Chao. “Does thalidomide affect IL-2 response and production?.” Exp Hematol 23, no. 9 (August 1995): 978–85.

PMID
7635184
Scholars@Duke

Pages